For both sides
Cannabis valuation for partner buyouts and disputes
Federal and state law current as of September 2026 — verify with counsel.
In a cannabis partner buyout or dispute, the value of a stake depends first on the standard of value that applies, not on the multiple. The operating agreement or state law decides whether the departing partner gets a pro rata share of the whole business, or fair market value with discounts for lack of control and marketability. Any resulting ownership change still needs cannabis regulator approval.
Key takeaways
- New York's highest court held in Friedman v. Beway Realty that fair value in a shareholder buyout excludes a minority discount, although a marketability discount may be considered.
- California lets LLC members avoid a judicial dissolution by buying out the petitioning members at fair market value, set by three court-appointed appraisers, valued as of the date the action was filed (Corp. Code 17707.03).
- In an illustrative business worth $3,000,000, a 30% stake is $900,000 pro rata and $535,500 after assumed 15% control and 30% marketability discounts, a gap of $364,500 from the standard of value alone.
- A buyout changes the ownership on file with the cannabis regulator, so it needs disclosure or prior approval like any other ownership change.
- With no bankruptcy option and lenders scarce, deadlocked cannabis partners risk a court-appointed receiver, which usually destroys more value than either side's position was worth.
Start with the standard of value, not the multiple
In a sale to an outside buyer, value is whatever the market pays. In a partner buyout there is no market test, so a document or a statute has to define what “value” means. Three definitions are common, and they give different answers for the same stake.
| Standard | What it means | Where it comes from | Discounts |
|---|---|---|---|
| Fair market value | Price between a hypothetical willing buyer and willing seller, neither compelled, both informed | Revenue Ruling 59-60; many operating agreements; some statutes | Lack-of-control and lack-of-marketability discounts commonly applied to a minority stake |
| Fair value (statutory) | The partner’s proportionate share of the business as a going concern | State dissenters’ rights, oppression, and buyout statutes | Minority discount usually rejected; marketability discount varies by state |
| Agreement value | Whatever the operating agreement says: a fixed price, a formula, or an appraisal process | The contract | Whatever the contract says |
Two examples show how state law differs.
- New York. In Friedman v. Beway Realty, the Court of Appeals held that fair value in a shareholder buyout does not include a discount for minority status, because that would hand the majority a windfall, while a discount for lack of marketability may still be considered. The reasoning and its later criticism are summarized by New York Business Divorce. See the New York page.
- California. When a member sues to dissolve an LLC, the other members can stop the dissolution by buying the petitioner out at fair market value. If the parties cannot agree, the court appoints three disinterested appraisers, and the valuation date is the day the action was filed unless the court orders otherwise, under Corporations Code 17707.03. See the California page.
Which rule governs your company depends on where the entity was formed and what the agreement says. That is a question for a business lawyer, and it comes before any valuation work.
Illustrative: one stake, three answers
Illustrative only. The business value and both discount percentages are assumptions to show the mechanics. They are not market data, and real discounts are set by an appraiser from evidence.
A cannabis company is worth $3,000,000 as a whole. One partner holds 30%.
| Standard | Calculation | Value of the 30% stake |
|---|---|---|
| Pro rata fair value, no discounts | $3,000,000 x 30% | $900,000 |
| Fair value with a marketability discount only (assumed 30%) | $900,000 x 70% | $630,000 |
| Fair market value with control (assumed 15%) and marketability (assumed 30%) discounts | $900,000 x 85% x 70% | $535,500 |
| Agreement formula written in 2021: 1.5 times trailing revenue of $4,000,000, times 30% | $6,000,000 x 30% | $1,800,000 |
The spread between the lowest and highest figure is more than three to one, and none of it comes from disagreement about the business. The last row is a common trap. Formulas drafted when public cannabis multiples were far higher can now require a buyout the company cannot afford. Viridian Capital put larger multi-state operators at a median 5.1x forward EBITDA in November 2025, down from 7.8x in June 2024, and private revenue-based formulas from earlier years are further still from today’s market.
Cannabis-specific issues inside the valuation
Whatever the standard, the appraiser still has to value the enterprise, and the usual cannabis problems apply. The methods are set out under valuation methods by license type. Points that cause the most argument between partners:
- Valuation date. Wholesale prices have fallen sharply in many states, and marijuana under a state medical license moved to Schedule III in April 2026. A date a year earlier or later can change the answer materially. See how oversupply and price compression affect value.
- 280E and unpaid tax. Accrued or disputed federal tax is a company liability that reduces equity value for every partner. The partner who ran the finances may face claims if returns were not filed. See how 280E affects valuation.
- Owner compensation and related-party dealings. A managing partner’s salary, a building owned by one partner and leased to the company, and management fees to an affiliate all need to be restated to market before earnings are capitalized.
- Marketability. A cannabis interest can be sold only to a buyer the regulator will approve, and many agreements add transfer restrictions of their own. Appraisers working under a fair market value standard treat that as support for a larger marketability discount. Under statutory fair value, some courts disregard it.
- Who holds the license qualifications. If the departing partner is the social equity qualifier, the local resident, or the only person with the required background, their exit may endanger the license. That affects the value of the whole company, not just the stake. See social equity license transfer restrictions.
The regulator is a party to every buyout
Cannabis regulators license people as well as entities. A buyout removes one owner and increases the others’ percentages, which is a reportable change almost everywhere.
- Washington vets every true party of interest, and changes in ownership require agency approval. See the Washington page.
- Massachusetts requires prior approval for changes of ownership or control under 935 CMR 500.104. See the Massachusetts page.
Practical consequences for valuation and timing:
- The buyout agreement should make closing conditional on approval, and say who runs the business meanwhile. The mechanics are covered under change of ownership approval.
- If the buyer of the stake is a new investor, that person must qualify. A price from an investor who cannot be approved is not evidence of value.
- A note to the departing partner may itself be a disclosable financial interest. See true party of interest and financial interest rules.
- A pledge of the purchased interest as security is enforceable only with regulator consent to the eventual transfer. See seller notes and security interests.
Buy-sell clauses: how they work and how they fail in cannabis
| Mechanism | How it sets the price | Cannabis weakness |
|---|---|---|
| Fixed price, updated annually | Partners sign a value each year | Rarely updated; stale within months in a falling market |
| Formula (multiple of revenue or EBITDA) | Arithmetic from the financial statements | Ignores 280E, price compression, and tax arrears; multiples drafted in boom years |
| Appraisal | One appraiser, or one per side with a third to break ties | Slow and costly, but adapts to current conditions; agreement should name the standard of value and address discounts |
| Shotgun (one names a price, the other chooses to buy or sell) | Self-policing in theory | Favors the partner with cash, and the partner who can be approved by the regulator |
| Right of first refusal on an outside offer | Market sets the price | Outside offers for minority cannabis stakes are rare |
An appraisal clause that names the standard of value, states whether discounts apply, fixes the valuation date, and requires an appraiser with cannabis experience prevents most disputes. The difference between a formal appraisal and a broker’s estimate is explained under appraisal vs broker opinion of value. In a dispute, the appraisal is the document that counts.
Deadlock, receivership, and the alternative of selling
Partners in an ordinary business who cannot agree can sometimes use bankruptcy to force a resolution. Plant-touching cannabis companies generally cannot. The fallback is a lawsuit for dissolution, and with it the risk that a court appoints a receiver. Lawyers at Husch Blackwell noted in November 2024 that cannabis receiverships were rising. A receiver’s fees come out of the company, the receiver must be qualified with the regulator, and sales out of receivership tend to clear at distressed prices, as shown under valuing a distressed cannabis business.
That arithmetic is the strongest argument for settling. If the partners are $300,000 apart on a $900,000 stake, and a receivership would plausibly cut enterprise value by far more than that, both are better off splitting the difference or selling the whole company to a third party and dividing the proceeds. A sale to an outsider also replaces the argument about hypothetical value with an actual price. The process is described in how to sell a cannabis business, and longer-range planning is covered in the guide to cannabis exit planning.
This page is educational. It is not legal, tax, or valuation advice. Partner disputes turn on the specific agreement and state law, and need a business lawyer and, where value is contested, an independent credentialed appraiser.
Frequently asked questions
My operating agreement sets a buyout formula. Does it override an appraisal?
Generally yes. Courts usually enforce a valuation method the partners agreed to in writing, even when it produces a figure far from current market value. That is why formulas written in 2019 or 2021, when multiples were much higher, cause fights today. Read the clause with counsel before commissioning any valuation, because it decides what the appraiser is asked to do.
Are minority discounts applied when one cannabis partner buys out another?
It depends on the governing agreement and state law. Under a fair market value standard, discounts for lack of control and lack of marketability are common. Under statutory fair value in many states, minority discounts are rejected so the majority does not profit from squeezing out a partner. Marketability discounts are treated differently from state to state.
Can I just pay my partner and update the cap table?
Not in a licensed cannabis business. Regulators license the owners as well as the entity. Removing or adding an owner, or moving percentages across a reporting threshold, requires notice or prior approval depending on the state. An undisclosed change can put the license at risk, which would damage the value both partners are arguing over.
Which valuation date applies in a partner dispute?
The agreement or statute usually fixes it, for example the date of the triggering event or the date a dissolution action was filed. In cannabis the date matters a great deal because wholesale prices and federal tax rules have moved quickly. A valuation as of early 2021 and one as of 2026 for the same business can differ by more than half.
How do partners fund a buyout when banks will not lend?
Mostly with installment payments from the company's own cash flow, a note to the departing partner secured by the purchased interest, a new investor, or a sale-leaseback of owned real estate. Under section 280E, an adult-use business has limited after-tax cash, so payment schedules need to be tested against realistic after-tax numbers.
Sources
- New York Business Divorce (Farrell Fritz) — The Marketability Discount in Fair Value Proceedings: An Emperor Without Clothes? (July 2011) — https://www.nybusinessdivorce.com/2011/07/articles/valuation-discounts/the-marketability-discount-in-fair-value-proceedings-an-emperor-without-clothes/
- California Legislative Information — Corporations Code 17707.03 — https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=CORP§ionNum=17707.03
- Tax Notes — Rev. Rul. 59-60 — https://www.taxnotes.com/research/federal/irs-guidance/revenue-rulings/rev-rul-59-60/d30t
- AICPA and CIMA — Statement on Standards for Valuation Services (VS Section 100) — https://www.aicpa-cima.com/resources/download/statement-on-standards-for-valuation-services-vs-section-100
- Cornell Legal Information Institute — WAC 314-55-035 Qualifying for a cannabis license (true parties of interest) — https://www.law.cornell.edu/regulations/washington/WAC-314-55-035
- Cornell Legal Information Institute — 935 CMR 500.104 Notification and Approval of Changes — https://www.law.cornell.edu/regulations/massachusetts/935-CMR-500-104
- Husch Blackwell, Cannabis Law Now — Cannabis Receiverships Are (and Will Be) On the Rise (21 Nov 2024) — https://www.cannabislawnow.com/2024/11/cannabis-receiverships-are-and-will-be-on-the-rise/
- Benzinga / Viridian Capital Advisors — Cannabis Chart of the Week: What Should MSO EBITDA Multiples Be? (June 2024) — https://www.benzinga.com/markets/cannabis/24/06/39269963/cannabis-chart-of-the-week-what-should-mso-ebitda-multiples-be
- Highly Capitalized — Viridian Capital Advisors Reports Valuation Metrics for U.S. MSOs with Market Caps over $100M (18 Nov 2025) — https://highlycapitalized.com/viridian-capital-advisors-reports-valuation-metrics-for-u-s-msos-with-market-caps-100m/